DocMorris AG (ZRSEF)
95.77
0.00 (0.00%)
USD |
OTCM |
Apr 24, 16:00
DocMorris Price to Book Value: 2.198 for April 24, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| April 24, 2024 | 2.198 |
| April 23, 2024 | 2.198 |
| April 22, 2024 | 2.198 |
| April 19, 2024 | 2.198 |
| April 18, 2024 | 2.198 |
| April 17, 2024 | 2.198 |
| April 16, 2024 | 2.198 |
| April 15, 2024 | 2.198 |
| April 12, 2024 | 2.198 |
| April 11, 2024 | 2.198 |
| April 10, 2024 | 2.198 |
| April 09, 2024 | 2.480 |
| April 08, 2024 | 2.480 |
| April 05, 2024 | 2.480 |
| April 04, 2024 | 2.480 |
| April 03, 2024 | 2.272 |
| April 02, 2024 | 2.272 |
| April 01, 2024 | 2.272 |
| March 28, 2024 | 2.033 |
| March 27, 2024 | 2.033 |
| March 26, 2024 | 2.033 |
| March 25, 2024 | 2.033 |
| March 22, 2024 | 2.033 |
| March 21, 2024 | 2.033 |
| March 20, 2024 | 2.033 |
| Date | Value |
|---|---|
| March 19, 2024 | 2.033 |
| March 18, 2024 | 2.033 |
| March 15, 2024 | 2.033 |
| March 14, 2024 | 2.033 |
| March 13, 2024 | 1.873 |
| March 12, 2024 | 1.873 |
| March 11, 2024 | 1.873 |
| March 08, 2024 | 1.873 |
| March 07, 2024 | 1.873 |
| March 06, 2024 | 1.873 |
| March 05, 2024 | 1.873 |
| March 04, 2024 | 1.873 |
| March 01, 2024 | 1.873 |
| February 29, 2024 | 1.873 |
| February 28, 2024 | 1.873 |
| February 27, 2024 | 1.873 |
| February 26, 2024 | 1.873 |
| February 23, 2024 | 1.873 |
| February 22, 2024 | 1.873 |
| February 21, 2024 | 1.873 |
| February 20, 2024 | 1.873 |
| February 16, 2024 | 1.873 |
| February 15, 2024 | 1.873 |
| February 14, 2024 | 1.873 |
| February 13, 2024 | 1.873 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
0.6996
Minimum
Jun 30 2023
8.602
Maximum
Feb 09 2021
3.219
Average
1.873
Median
Jan 18 2024
Price to Book Value Benchmarks
| AC Immune SA | 1.226 |
| CRISPR Therapeutics AG | 2.509 |
| Addex Therapeutics Ltd | 12.19 |
| NLS Pharmaceutics Ltd | -- |
| Molecular Partners AG | 0.6069 |
Price to Book Value Related Metrics
| PE Ratio | 12.34 |
| PS Ratio | 1.029 |
| Price | 95.77 |
| Earnings Yield | 8.11% |
| Market Cap | 1.126B |